Iceland· IS-EU/1/09/605/001-002
Temomedac
A temozolomide product containing temozolomidum inn, registered in Iceland by Medac Gesellschaft fuer klinische Spezialpraeparate mbH. The same ATC class is registered in 17 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Temozolomide is registered in 17 of 19 countries.
Countries holding a registration under ATC L01AX03 (temozolomide), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 10 of them publish a price we can compare per daily dose
Temozolomide · ATC L01AX03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of temozolomide costs, country by country.
Normalised to the WHO defined daily dose (65 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Temozolomide · price per daily dose (65 mg)
USD · FX 28 Sept 2026
- IT Italy$43.87
- CH Switzerland$34.49
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Temozolomidum INN
- Manufacturer
- Medac Gesellschaft fuer klinische Spezialpraeparate mbH
- Country
- Iceland (IS)
- ATC code
- L01AX03
- ATC class
- Temozolomide
- Defined daily dose
- 65 mg, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
354 interactions on record for temozolomide.
Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Temozolomide · interactions on record
354 records
- 33 severe
- 103 moderate
- 16 minor
- 202 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CladribineL01BB04severe
- PexidartinibL01EX15severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Temozolomide in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsBlastomat 5 mg, harde capsulesZentiva k.s.
- SpainTEMODAL 5 MG CAPSULAS DURASMerck Sharp & Dohme B.V.
- United StatesTEMODARMerck Sharp & Dohme LLC
- CzechiaTEMODALMerck Sharp & Dohme B.V., Haarlem
- United KingdomTemodal 5mg capsulesMerck Sharp & Dohme (UK) Ltd
- BelgiumTemodal 5 mgMerck Sharp & Dohme
- FinlandTemodalMerck Sharp & Dohme B.V.
- SwedenTemodal 5 mg Kapsel, hårdMerck Sharp & Dohme BV
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Cyprus · Advecit, Ridoca
- Czechia · Temozolomide Glenmark
- Germany · Temozo-Cell, Temozolomid Cipla
- Denmark · Temozolomid Fair-Med, Temozolomid Stada
- Estonia · Blastomat
- Finland · Temozolomid Ratiopharm
- France · Kimozo, Temozolomide Viatris
- United Kingdom (Northern Ireland) · Temozolomide, Temozolomide Crescent Pharma
- Greece · Ridoca
- Croatia · Temazol, Temozolomid Pgf Pharma
- Hungary · Temozolomide Pharmacenter
- Ireland · Temozolomide Clonmel, Temozolomide Fair-Med
- Liechtenstein · Temodal, Temomedac
- Lithuania · Blastomat
- Latvia · Blastomat
- Malta · Temozolomide Clonmel 100mg Hard Capsules, Temozolomide Clonmel 140mg Hard Capsules
- Netherlands · Blastomat, Nogron
- Norway · Temodal, Temomedac
- Poland · Temozolomide Fair-Med, Temozolomide Glenmark
- Portugal · Temozolomida, Temozolomide
- Romania · Temozolomidă Hf
- Sweden · Temozolomid Stada, Temozolomide Pgf Pharma
- Slovakia · Temostad
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8fa1614-3ea6-47a0-bde6-e6b2835a290e GET /v1/drugs/e8fa1614-3ea6-47a0-bde6-e6b2835a290e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Hart hylki",
"source": "lyfjastofnun",
"atc_raw": "L01AX03",
"marketed": false,
"strength": "5 mg",
"ma_number": "EU/1/09/605/001-002",
"substance": "Temozolomidum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í krabbameinslækningum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "40233"
}See everything about temozolomide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.